Evidence map›Paper›PMID 26869673›Full record

ArticleThe European respiratory journal2016

Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma.

Despo Ierodiakonou, Michael A Portelli, Dirkje S Postma, Gerard H Koppelman, Jorrit Gerritsen, Nick H T Ten Hacken, Wim Timens, H Marike Boezen, Judith M Vonk, Ian Sayers

Open access · hybridAbstract readLetter
In one paragraph

Article in The European respiratory journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The Association ofInternational journal of molecular sciences · 2022
    Article
  5. Article
  6. Review
  7. Fibrinogen Is a Specific Trigger for Cytolytic Eosinophil Degranulation.Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Despo IerodiakonouDept of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Both authors contributed equally.
Michael A PortelliDivision of Respiratory Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, UK Both authors contributed equally.
Dirkje S PostmaGroningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Dept of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Gerard H KoppelmanGroningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Dept of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Jorrit GerritsenGroningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Dept of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Nick H T Ten HackenGroningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Dept of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Wim TimensGroningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Dept of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
H Marike BoezenDept of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Judith M VonkDept of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Ian SayersDivision of Respiratory Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, UK ian.sayers@nottingham.ac.uk.
University Medical Center Groningen · NLUniversity of Groningen · NLUniversity of Nottingham · GB

Funding

Medical Research Council G0400283
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Airway RemodelingAsthmaBronchiHumansPlasminogenPolymorphism, GeneticPolymorphism, Single NucleotideUrokinase-Type Plasminogen ActivatorPlasminogenUrokinase-Type Plasminogen Activator

Identifiers

PMID26869673
PMCPMC4851936
OpenAlexW2340835235

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.